Pfizer, Valneva conclude recruitment for Phase 3 trial for Lyme Disease Vaccine candidate VLA15 Ruchika Sharma8 Dec 2023 2:30 PM ISTNew York: Pfizer Inc. and Valneva SE have announced that they have completed recruitment for the Phase 3 trial Vaccine Against Lyme for Outdoor...
Pfizer, Valneva report positive pediatric, adolescent phase 2 booster results for Lyme disease vaccine Ruchika Sharma10 Sept 2023 2:30 PM ISTNew York: Valneva SE and Pfizer Inc. have announced positive pediatric and adolescent immunogenicity and safety data for their Lyme...
Pfizer to acquire 8.1 percent stake in Valneva Ruchika Sharma20 Jun 2022 10:30 AM ISTValneva is planning to use the proceeds from Pfizer's equity investment to support its Phase 3 development contribution to the Lyme disease program.
Pfizer-Valneva Lyme vaccine pact sees HSR clearance Ruchika Sharma10 Jun 2020 9:00 AM ISTUnder the terms of the Agreement, Valneva and Pfizer will work closely together throughout the development of VLA15. Valneva is eligible to receive a...
